Chamath Palihapitiya Has Invested in 14 Different SPACs and PIPEs — Which Are the Best Buys Now?

1 min read

Many investors are familiar with Chamath Palihapitiya’s SPACs, which have taken Virgin Galactic Holdings, Opendoor Technologies, and Clover Health (NASDAQ: CLOV) public, but many aren’t familiar with the other SPAC deals he’s backed through private finding rounds known as PIPEs. In this Fool Live video clip, recorded on March 15, Fool.com contributors Matt Frankel, CFP, Brian Withers, and Dan Caplinger discuss which of the 14 SPACs and PIPEs Palihapitiya has participated in are their favorite long-term investment opportunities.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Is OrganiGram Stock a Buy After British American Tobacco’s Investment?

Next Story

This Tech Stock’s Growth Should Pick Up Speed After Earnings

Latest from Blog